세계의 원내 감염 치료제 시장 (2023년~2027년)

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global hospital infection therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global hospital infection therapeutics market 2017 – 2021 ($ million)
o 4.2 Drug Class Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Drug Class Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Drug Class – Market share 2022-2027 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Antibiotics drugs – Market size and forecast 2022-2027
o Exhibit 34: Chart on Antibiotics drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Antibiotics drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Antibiotics drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Antibiotics drugs – Year-over-year growth 2022-2027 (%)
o 6.4 Antifungal drugs – Market size and forecast 2022-2027
o Exhibit 38: Chart on Antifungal drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Antifungal drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Antifungal drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Antifungal drugs – Year-over-year growth 2022-2027 (%)
o 6.5 Antiviral drugs – Market size and forecast 2022-2027
o Exhibit 42: Chart on Antiviral drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Antiviral drugs – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Antiviral drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Antiviral drugs – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Drug Class
o Exhibit 46: Market opportunity by Drug Class ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 47: Chart on Type – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 49: Chart on Comparison by Type
o Exhibit 50: Data Table on Comparison by Type
o 7.3 Respiratory tract infections – Market size and forecast 2022-2027
o Exhibit 51: Chart on Respiratory tract infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Respiratory tract infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Respiratory tract infections – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Respiratory tract infections – Year-over-year growth 2022-2027 (%)
o 7.4 Surgical site infections – Market size and forecast 2022-2027
o Exhibit 55: Chart on Surgical site infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Surgical site infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Surgical site infections – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Surgical site infections – Year-over-year growth 2022-2027 (%)
o 7.5 Bloodstream infections – Market size and forecast 2022-2027
o Exhibit 59: Chart on Bloodstream infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Bloodstream infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Bloodstream infections – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Bloodstream infections – Year-over-year growth 2022-2027 (%)
o 7.6 Gastrointestinal infections – Market size and forecast 2022-2027
o Exhibit 63: Chart on Gastrointestinal infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Gastrointestinal infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Gastrointestinal infections – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Gastrointestinal infections – Year-over-year growth 2022-2027 (%)
o 7.7 Urinary tract infections – Market size and forecast 2022-2027
o Exhibit 67: Chart on Urinary tract infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Urinary tract infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Urinary tract infections – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Urinary tract infections – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Type
o Exhibit 71: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share by geography 2022-2027 (%)
o Exhibit 74: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 77: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 93: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 101: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 105: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 109: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 113: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 120: Abbott Laboratories – Overview
o Exhibit 121: Abbott Laboratories – Business segments
o Exhibit 122: Abbott Laboratories – Key news
o Exhibit 123: Abbott Laboratories – Key offerings
o Exhibit 124: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 125: AbbVie Inc. – Overview
o Exhibit 126: AbbVie Inc. – Product / Service
o Exhibit 127: AbbVie Inc. – Key news
o Exhibit 128: AbbVie Inc. – Key offerings
o 12.5 Achilles Therapeutics plc
o Exhibit 129: Achilles Therapeutics plc – Overview
o Exhibit 130: Achilles Therapeutics plc – Product / Service
o Exhibit 131: Achilles Therapeutics plc – Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 132: AstraZeneca Plc – Overview
o Exhibit 133: AstraZeneca Plc – Product / Service
o Exhibit 134: AstraZeneca Plc – Key news
o Exhibit 135: AstraZeneca Plc – Key offerings
o 12.7 Bayer AG
o Exhibit 136: Bayer AG – Overview
o Exhibit 137: Bayer AG – Business segments
o Exhibit 138: Bayer AG – Key news
o Exhibit 139: Bayer AG – Key offerings
o Exhibit 140: Bayer AG – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 141: Bristol Myers Squibb Co. – Overview
o Exhibit 142: Bristol Myers Squibb Co. – Product / Service
o Exhibit 143: Bristol Myers Squibb Co. – Key news
o Exhibit 144: Bristol Myers Squibb Co. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 145: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 146: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 147: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 148: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 149: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Gilead Sciences Inc.
o Exhibit 150: Gilead Sciences Inc. – Overview
o Exhibit 151: Gilead Sciences Inc. – Product / Service
o Exhibit 152: Gilead Sciences Inc. – Key news
o Exhibit 153: Gilead Sciences Inc. – Key offerings
o 12.11 GlaxoSmithKline Plc
o Exhibit 154: GlaxoSmithKline Plc – Overview
o Exhibit 155: GlaxoSmithKline Plc – Business segments
o Exhibit 156: GlaxoSmithKline Plc – Key offerings
o Exhibit 157: GlaxoSmithKline Plc – Segment focus
o 12.12 Johnson and Johnson
o Exhibit 158: Johnson and Johnson – Overview
o Exhibit 159: Johnson and Johnson – Business segments
o Exhibit 160: Johnson and Johnson – Key news
o Exhibit 161: Johnson and Johnson – Key offerings
o Exhibit 162: Johnson and Johnson – Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 163: Merck and Co. Inc. – Overview
o Exhibit 164: Merck and Co. Inc. – Business segments
o Exhibit 165: Merck and Co. Inc. – Key news
o Exhibit 166: Merck and Co. Inc. – Key offerings
o Exhibit 167: Merck and Co. Inc. – Segment focus
o 12.14 Novartis AG
o Exhibit 168: Novartis AG – Overview
o Exhibit 169: Novartis AG – Business segments
o Exhibit 170: Novartis AG – Key offerings
o Exhibit 171: Novartis AG – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 172: Pfizer Inc. – Overview
o Exhibit 173: Pfizer Inc. – Product / Service
o Exhibit 174: Pfizer Inc. – Key news
o Exhibit 175: Pfizer Inc. – Key offerings
o 12.16 Sanofi SA
o Exhibit 176: Sanofi SA – Overview
o Exhibit 177: Sanofi SA – Business segments
o Exhibit 178: Sanofi SA – Key news
o Exhibit 179: Sanofi SA – Key offerings
o Exhibit 180: Sanofi SA – Segment focus
o 12.17 Viatris Inc.
o Exhibit 181: Viatris Inc. – Overview
o Exhibit 182: Viatris Inc. – Business segments
o Exhibit 183: Viatris Inc. – Key offerings
o Exhibit 184: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 185: Inclusions checklist
o Exhibit 186: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 187: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 188: Research methodology
o Exhibit 189: Validation techniques employed for market sizing
o Exhibit 190: Information sources
o 13.5 List of abbreviations
o Exhibit 191: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global hospital infection therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Drug Class Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Drug Class – Market share 2022-2027 (%)
Exhibits31: Data Table on Drug Class – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Antibiotics drugs – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antibiotics drugs – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antibiotics drugs – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antibiotics drugs – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Antifungal drugs – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Antifungal drugs – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Antifungal drugs – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Antifungal drugs – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Antiviral drugs – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Antiviral drugs – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Antiviral drugs – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Antiviral drugs – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Drug Class ($ million)
Exhibits47: Chart on Type – Market share 2022-2027 (%)
Exhibits48: Data Table on Type – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Type
Exhibits50: Data Table on Comparison by Type
Exhibits51: Chart on Respiratory tract infections – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Respiratory tract infections – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Respiratory tract infections – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Respiratory tract infections – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Surgical site infections – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Surgical site infections – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Surgical site infections – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Surgical site infections – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Bloodstream infections – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Bloodstream infections – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Bloodstream infections – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Bloodstream infections – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Gastrointestinal infections – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Gastrointestinal infections – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Gastrointestinal infections – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Gastrointestinal infections – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Urinary tract infections – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Urinary tract infections – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Urinary tract infections – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Urinary tract infections – Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Type ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share by geography 2022-2027 (%)
Exhibits74: Data Table on Market share by geography 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity by geography ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Abbott Laboratories – Overview
Exhibits121: Abbott Laboratories – Business segments
Exhibits122: Abbott Laboratories – Key news
Exhibits123: Abbott Laboratories – Key offerings
Exhibits124: Abbott Laboratories – Segment focus
Exhibits125: AbbVie Inc. – Overview
Exhibits126: AbbVie Inc. – Product / Service
Exhibits127: AbbVie Inc. – Key news
Exhibits128: AbbVie Inc. – Key offerings
Exhibits129: Achilles Therapeutics plc – Overview
Exhibits130: Achilles Therapeutics plc – Product / Service
Exhibits131: Achilles Therapeutics plc – Key offerings
Exhibits132: AstraZeneca Plc – Overview
Exhibits133: AstraZeneca Plc – Product / Service
Exhibits134: AstraZeneca Plc – Key news
Exhibits135: AstraZeneca Plc – Key offerings
Exhibits136: Bayer AG – Overview
Exhibits137: Bayer AG – Business segments
Exhibits138: Bayer AG – Key news
Exhibits139: Bayer AG – Key offerings
Exhibits140: Bayer AG – Segment focus
Exhibits141: Bristol Myers Squibb Co. – Overview
Exhibits142: Bristol Myers Squibb Co. – Product / Service
Exhibits143: Bristol Myers Squibb Co. – Key news
Exhibits144: Bristol Myers Squibb Co. – Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. – Overview
Exhibits146: F. Hoffmann La Roche Ltd. – Business segments
Exhibits147: F. Hoffmann La Roche Ltd. – Key news
Exhibits148: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits150: Gilead Sciences Inc. – Overview
Exhibits151: Gilead Sciences Inc. – Product / Service
Exhibits152: Gilead Sciences Inc. – Key news
Exhibits153: Gilead Sciences Inc. – Key offerings
Exhibits154: GlaxoSmithKline Plc – Overview
Exhibits155: GlaxoSmithKline Plc – Business segments
Exhibits156: GlaxoSmithKline Plc – Key offerings
Exhibits157: GlaxoSmithKline Plc – Segment focus
Exhibits158: Johnson and Johnson – Overview
Exhibits159: Johnson and Johnson – Business segments
Exhibits160: Johnson and Johnson – Key news
Exhibits161: Johnson and Johnson – Key offerings
Exhibits162: Johnson and Johnson – Segment focus
Exhibits163: Merck and Co. Inc. – Overview
Exhibits164: Merck and Co. Inc. – Business segments
Exhibits165: Merck and Co. Inc. – Key news
Exhibits166: Merck and Co. Inc. – Key offerings
Exhibits167: Merck and Co. Inc. – Segment focus
Exhibits168: Novartis AG – Overview
Exhibits169: Novartis AG – Business segments
Exhibits170: Novartis AG – Key offerings
Exhibits171: Novartis AG – Segment focus
Exhibits172: Pfizer Inc. – Overview
Exhibits173: Pfizer Inc. – Product / Service
Exhibits174: Pfizer Inc. – Key news
Exhibits175: Pfizer Inc. – Key offerings
Exhibits176: Sanofi SA – Overview
Exhibits177: Sanofi SA – Business segments
Exhibits178: Sanofi SA – Key news
Exhibits179: Sanofi SA – Key offerings
Exhibits180: Sanofi SA – Segment focus
Exhibits181: Viatris Inc. – Overview
Exhibits182: Viatris Inc. – Business segments
Exhibits183: Viatris Inc. – Key offerings
Exhibits184: Viatris Inc. – Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations